ID ZN746_HUMAN Reviewed; 644 AA. AC Q6NUN9; A8K6Z9; Q6ZRF9; DT 17-OCT-2006, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2004, sequence version 1. DT 27-MAR-2024, entry version 160. DE RecName: Full=Zinc finger protein 746 {ECO:0000305}; DE AltName: Full=Parkin-interacting substrate; DE Short=PARIS; GN Name=ZNF746 {ECO:0000312|HGNC:HGNC:21948}; Synonyms=PARIS; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3). RC TISSUE=Prostate, and Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12853948; DOI=10.1038/nature01782; RA Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., RA Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., RA Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., RA Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H., RA Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A., RA Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P., RA Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M., RA Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S., RA Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., RA Strowmatt C., Latreille P., Miller N., Johnson D., Murray J., RA Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., RA Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., RA Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E., RA Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E., RA Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A., RA Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A., RA Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R., RA McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H., RA Wilson R.K.; RT "The DNA sequence of human chromosome 7."; RL Nature 424:157-164(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, SUBCELLULAR LOCATION, UBIQUITINATION, AND MUTAGENESIS OF CYS-458; RP HIS-471; CYS-518; HIS-528; CYS-543; HIS-560; CYS-571 AND HIS-584. RX PubMed=21376232; DOI=10.1016/j.cell.2011.02.010; RA Shin J.H., Ko H.S., Kang H., Lee Y., Lee Y.I., Pletinkova O., RA Troconso J.C., Dawson V.L., Dawson T.M.; RT "PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration RT in Parkinson's disease."; RL Cell 144:689-702(2011). RN [5] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-282 AND LYS-286, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). RN [6] RP FUNCTION, SUBUNIT, AND INTERACTION WITH TRIM28. RX PubMed=31856708; DOI=10.1186/s12860-019-0243-y; RA Al Chiblak M., Steinbeck F., Thiesen H.J., Lorenz P.; RT "DUF3669, a 'domain of unknown function' within ZNF746 and ZNF777, RT oligomerizes and contributes to transcriptional repression."; RL BMC Mol. Cell Biol. 20:60-60(2019). CC -!- FUNCTION: Transcription repressor that specifically binds to the 5'- CC TATTTT[T/G]-3' consensus sequence on promoters and repress CC transcription of PGC-1-alpha (PPARGC1A), thereby playing a role in CC regulation of neuron death. {ECO:0000269|PubMed:21376232, CC ECO:0000269|PubMed:31856708}. CC -!- SUBUNIT: Homooligomer, heterooligomer with ZNF746 (PubMed:31856708). CC Interacts (via C2H2-type zinc fingers) with PRKN (By similarity). CC {ECO:0000250|UniProtKB:Q3U133, ECO:0000269|PubMed:31856708}. CC -!- SUBUNIT: [Isoform 1]: Interacts with TRIM28. CC {ECO:0000269|PubMed:31856708}. CC -!- INTERACTION: CC Q6NUN9; O60260: PRKN; NbExp=6; IntAct=EBI-3862525, EBI-716346; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21376232}. Nucleus CC {ECO:0000305|PubMed:21376232}. Note=Mainly localizes to the cytoplasm; CC probably translocates to the nucleus to repress selected genes. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q6NUN9-1; Sequence=Displayed; CC Name=2; CC IsoId=Q6NUN9-2; Sequence=VSP_041053; CC Name=3; CC IsoId=Q6NUN9-3; Sequence=VSP_041052; CC -!- PTM: Ubiquitinated by PRKN. 'Lys-48'-linked polyubiquitination by PRKN CC leads to degradation by the proteasome and may play a key role in CC regulation of neuron death. {ECO:0000269|PubMed:21376232}. CC -!- MISCELLANEOUS: May act as a downstream effector of PRKN and contribute CC to neurodegeneration in Parkinson disease cases caused by defects in CC PRKN: its accumulation due to the absence of PRKN, followed by up- CC regulation of PPARGC1A, could lead to the selective loss of dopamine CC neurons in the substantia nigra. {ECO:0000305|PubMed:21376232}. CC -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein CC family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK128244; BAC87351.1; -; mRNA. DR EMBL; AK291814; BAF84503.1; -; mRNA. DR EMBL; AC073314; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC068505; AAH68505.1; -; mRNA. DR CCDS; CCDS55180.1; -. [Q6NUN9-2] DR CCDS; CCDS5897.1; -. [Q6NUN9-1] DR RefSeq; NP_001156946.1; NM_001163474.1. [Q6NUN9-2] DR RefSeq; NP_689770.3; NM_152557.4. [Q6NUN9-1] DR AlphaFoldDB; Q6NUN9; -. DR SMR; Q6NUN9; -. DR BioGRID; 127574; 320. DR IntAct; Q6NUN9; 36. DR MINT; Q6NUN9; -. DR STRING; 9606.ENSP00000493970; -. DR iPTMnet; Q6NUN9; -. DR PhosphoSitePlus; Q6NUN9; -. DR BioMuta; ZNF746; -. DR DMDM; 74736828; -. DR EPD; Q6NUN9; -. DR jPOST; Q6NUN9; -. DR MassIVE; Q6NUN9; -. DR MaxQB; Q6NUN9; -. DR PaxDb; 9606-ENSP00000395007; -. DR PeptideAtlas; Q6NUN9; -. DR ProteomicsDB; 66696; -. [Q6NUN9-1] DR ProteomicsDB; 66697; -. [Q6NUN9-2] DR ProteomicsDB; 66698; -. [Q6NUN9-3] DR Pumba; Q6NUN9; -. DR ABCD; Q6NUN9; 1 sequenced antibody. DR Antibodypedia; 46329; 74 antibodies from 21 providers. DR DNASU; 155061; -. DR Ensembl; ENST00000340622.8; ENSP00000345140.3; ENSG00000181220.18. [Q6NUN9-1] DR Ensembl; ENST00000685153.1; ENSP00000508891.1; ENSG00000181220.18. [Q6NUN9-2] DR GeneID; 155061; -. DR KEGG; hsa:155061; -. DR UCSC; uc003wfw.3; human. [Q6NUN9-1] DR AGR; HGNC:21948; -. DR CTD; 155061; -. DR DisGeNET; 155061; -. DR GeneCards; ZNF746; -. DR HGNC; HGNC:21948; ZNF746. DR HPA; ENSG00000181220; Low tissue specificity. DR MIM; 613914; gene. DR neXtProt; NX_Q6NUN9; -. DR OpenTargets; ENSG00000181220; -. DR PharmGKB; PA144596520; -. DR VEuPathDB; HostDB:ENSG00000181220; -. DR eggNOG; KOG1721; Eukaryota. DR GeneTree; ENSGT00940000161747; -. DR HOGENOM; CLU_002678_76_3_1; -. DR InParanoid; Q6NUN9; -. DR OrthoDB; 4614113at2759; -. DR PhylomeDB; Q6NUN9; -. DR TreeFam; TF337777; -. DR PathwayCommons; Q6NUN9; -. DR Reactome; R-HSA-212436; Generic Transcription Pathway. DR SignaLink; Q6NUN9; -. DR SIGNOR; Q6NUN9; -. DR BioGRID-ORCS; 155061; 7 hits in 1175 CRISPR screens. DR ChiTaRS; ZNF746; human. DR GenomeRNAi; 155061; -. DR Pharos; Q6NUN9; Tbio. DR PRO; PR:Q6NUN9; -. DR Proteomes; UP000005640; Chromosome 7. DR RNAct; Q6NUN9; Protein. DR Bgee; ENSG00000181220; Expressed in blood and 164 other cell types or tissues. DR ExpressionAtlas; Q6NUN9; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IC:ParkinsonsUK-UCL. DR GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:ParkinsonsUK-UCL. DR GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB. DR GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB. DR GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:ParkinsonsUK-UCL. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:ParkinsonsUK-UCL. DR GO; GO:0051291; P:protein heterooligomerization; IDA:UniProtKB. DR GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB. DR CDD; cd07765; KRAB_A-box; 1. DR Gene3D; 6.10.140.140; -; 1. DR Gene3D; 3.30.160.60; Classic Zinc Finger; 4. DR InterPro; IPR001909; KRAB. DR InterPro; IPR036051; KRAB_dom_sf. DR InterPro; IPR036236; Znf_C2H2_sf. DR InterPro; IPR013087; Znf_C2H2_type. DR PANTHER; PTHR23232; KRAB DOMAIN C2H2 ZINC FINGER; 1. DR PANTHER; PTHR23232:SF145; ZINC FINGER PROTEIN 746-RELATED; 1. DR Pfam; PF01352; KRAB; 1. DR Pfam; PF00096; zf-C2H2; 4. DR SMART; SM00349; KRAB; 1. DR SMART; SM00355; ZnF_C2H2; 4. DR SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 3. DR SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1. DR PROSITE; PS50805; KRAB; 1. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4. DR Genevisible; Q6NUN9; HS. PE 1: Evidence at protein level; KW Alternative splicing; Coiled coil; Cytoplasm; DNA-binding; Isopeptide bond; KW Metal-binding; Nucleus; Reference proteome; Repeat; Repressor; KW Transcription; Transcription regulation; Ubl conjugation; Zinc; KW Zinc-finger. FT CHAIN 1..644 FT /note="Zinc finger protein 746" FT /id="PRO_0000253728" FT DOMAIN 96..167 FT /note="KRAB" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00119" FT ZN_FING 453..478 FT /note="C2H2-type 1; degenerate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 510..532 FT /note="C2H2-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 538..560 FT /note="C2H2-type 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 566..588 FT /note="C2H2-type 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT REGION 153..176 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 324..370 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 472..503 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 581..623 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 16..92 FT /evidence="ECO:0000255" FT COMPBIAS 598..614 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CROSSLNK 282 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 286 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT VAR_SEQ 1..185 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_041052" FT VAR_SEQ 279 FT /note="E -> EA (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_041053" FT MUTAGEN 458 FT /note="C->A: No effect." FT /evidence="ECO:0000269|PubMed:21376232" FT MUTAGEN 471 FT /note="H->A: No effect." FT /evidence="ECO:0000269|PubMed:21376232" FT MUTAGEN 518 FT /note="C->A: No effect." FT /evidence="ECO:0000269|PubMed:21376232" FT MUTAGEN 528 FT /note="H->A: No effect." FT /evidence="ECO:0000269|PubMed:21376232" FT MUTAGEN 543 FT /note="C->A: No effect." FT /evidence="ECO:0000269|PubMed:21376232" FT MUTAGEN 560 FT /note="H->A: No effect." FT /evidence="ECO:0000269|PubMed:21376232" FT MUTAGEN 571 FT /note="C->A: Impairs DNA-binding and ability to repress FT PGC-1-alpha (PPARGC1A)." FT /evidence="ECO:0000269|PubMed:21376232" FT MUTAGEN 584 FT /note="H->A: No effect." FT /evidence="ECO:0000269|PubMed:21376232" SQ SEQUENCE 644 AA; 69136 MW; 4F6723D2225D95AB CRC64; MAEAVAAPIS PWTMAATIQA MERKIESQAA RLLSLEGRTG MAEKKLADCE KTAVEFGNQL EGKWAVLGTL LQEYGLLQRR LENVENLLRN RNFWILRLPP GSKGESPKEW GKLEDWQKEL YKHVMRGNYE TLVSLDYAIS KPEVLSQIEQ GKEPCNWRRP GPKIPDVPVD PSPGSGPPVP APDLLMQIKQ EGELQLQEQQ ALGVEAWAAG QPDIGEEPWG LSQLDSGAGD ISTDATSGVH SNFSTTIPPT SWQTDLPPHH PSSACSDGTL KLNTAASTED VKIVIKTEVQ EEEVVATPVH PTDLEAHGTL FGPGQATRFF PSPAQEGAWE SQGSSFPSQD PVLGLREPAR PERDMGELSP AVAQEETPPG DWLFGGVRWG WNFRCKPPVG LNPRTGPEGL PYSSPDNGEA ILDPSQAPRP FNEPCKYPGR TKGFGHKPGL KKHPAAPPGG RPFTCATCGK SFQLQVSLSA HQRSCGAPDG SGPGTGGGGS GSGGGGGGSG GGSARDGSAL RCGECGRCFT RPAHLIRHRM LHTGERPFPC TECEKRFTER SKLIDHYRTH TGVRPFTCTV CGKSFIRKDH LRKHQRNHAA GAKTPARGQP LPTPPAPPDP FKSPASKGPL ASTDLVTDWT CGLSVLGPTD GGDM //